BELL fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Belluscura Plc engages in the provision of medical devices. The firm focuses on developing oxygen enrichment technology spanning broad industries and therapies. Its oxygen technologies are designed with a global purpose to create improved health and economic outcomes for the patients, healthcare providers and insurance organizations. The company was founded on December 10, 2015 and is headquartered in London, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
BELL has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company